FDA seeks comments on combined-function molecular Dx proposal

04/11/2013 | GenomeWeb Daily News (free registration)

The FDA has released draft guidance on how it intends to regulate molecular diagnostic systems with combined functions. The agency is seeking comments on the guidance, which covers issues such as submission data, device labeling and promotion, and modifications of software and hardware.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care